Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05606731 · ClinicalTrials.gov registry record · NA
Family Intervention to Prevent Childhood Obesity
A NA study of Childhood Obesity, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 182
- Enrollment target
- 1
- Study location
NCT05606731: Recruiting NA study of Childhood Obesity, sponsored by University of California, Los Angeles.
NCT05606731 is a NA study of Childhood Obesity that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 182 participants, below the 556-participant average among 43 other Childhood Obesity trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05606731, a NA study of Childhood Obesity, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
- 1
- Study location
Study Summary
Consumption of sweetened beverages, media-viewing, and physical activity patterns are often established during early childhood, and family-based obesity interventions show effectiveness in shaping healthy behaviors and weight outcomes for young children, including Latino children. Missing from these interventions, however, are methods to increase accessibility and dissemination to multiple family caregivers. The proposed work will use a randomized study design to evaluate the impact a family-based early childhood obesity intervention for Latino families that incorporates evidence-based strategies of in-person childhood obesity interventions, mobile phones, and leverages important determinants of Latino health (e.g. familism, language) in order to decrease ethnic disparities in childhood obesity and cardiovascular risk.
Primary Outcome
BMI in kg/m\^2 based on measured weight in kg and height in meters.
Conditions Studied
Interventions
- BEHAVIORAL Family-Based Childhood Obesity Intervention
Study Locations (1)
California
- Head Start - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2023-11-06 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05606731 shows while recruiting
NCT05606731 is an interventional study that assigns participants to a tested intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 556-participant average among 43 other Childhood Obesity trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Childhood Obesity appearing as the primary indexed condition, and to 1 intervention - of which Family-Based Childhood Obesity Intervention is the first listed.
NCT05606731 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05606731 about?
NCT05606731 is a clinical study titled "Family Intervention to Prevent Childhood Obesity". Consumption of sweetened beverages, media-viewing, and physical activity patterns are often established during early childhood, and family-based obesity interventions show effectiveness in shaping healthy behaviors and weight outcomes for young children, including Latino children. Missing from these...
What is the current status of trial NCT05606731?
This trial is currently recruiting. It is a NA study. The enrollment target is 182 participants. The study started on 2023-11-06. Estimated completion is 2026-12-31.
What conditions does trial NCT05606731 study?
This clinical trial studies the following conditions: Childhood Obesity.
What interventions are being tested in trial NCT05606731?
The interventions under investigation include: Family-Based Childhood Obesity Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05606731?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05606731 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05606731's enrollment target sits among peer trials
182 22nd of 43 higher than 22 of 43 other Childhood Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Childhood Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integrating Food Rx With Best Feeding Practices With EFNEP
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
Genetic Risk, Parental Feeding Practices, and Appetitive Traits in Early Life
RECRUITING · NA
-
Maternal Smoking Cessation and Pediatric Obesity Prevention
RECRUITING · NA
-
Mountain West Prevention Research Center Core Research Project
RECRUITING · NA
-
The Dose Trial: Dose Intensity of Behavioral Interventions for Childhood Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT06084936 · 182 participants · Phase 3
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI